Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Jamie Lopez Bernal, Nick Andrews, Charlotte Gower et al. · New England Journal of Medicine · 2021 · 3.1K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas, David Veyer, Artem Baidaliuk et al. · Nature · 2021 · 2.2K citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer, Tali Eviatar, Devy Zisman et al. · Annals of the Rheumatic Diseases · 2021 · 691 citations · Full text

Veterinary Medicine, Immunology, Autoimmunity +15

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

The Lancet · 2021 · 685 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

Emma K. Accorsi, Amadea Britton, Katherine E. Fleming-Dutra et al. · JAMA · 2022 · 683 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17